Proposed Methodologies For EU Joint Clinical Assessment Are Threat To ATMPs and Rare Disease Patients

 
• By Francesca Bruce
  
Gene therapy
Proposed Methodologies for new joint clinical assessments are not suitable for ATMPs • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography